INNOVATE Corp.
INNOVATE is a diversified holding company with operating platforms in Infrastructure, Life Sciences and Spectrum, as well as an Other segment for businesses and investments that do not meet segment thresholds. Its subsidiaries include DBM Global, which provides structural and steel construction services; Pansend Life Sciences, which supports healthcare and biotechnology product development and holds interests in healthcare companies; and HC2 Broadcasting, which operates over-the-air broadcasting stations across the United States, including Puerto Rico. INNOVATE is headquartered in New York, NY. DBM Global earns money through construction and professional services, including steel design, fabrication and erection, industrial construction, maintenance, digital engineering and equipment manufacturing. Pansend’s portfolio includes companies developing products and technologies for orthopedics, skin treatments and other healthcare applications. R2 Technologies develops aesthetic devices, including its Glacial product platform, and sells systems to medical practices, spas and other customers through distribution arrangements.
No SEC Form 4 filings for $VATE in the last 30 days.
See all $VATE insider activity →Innovate Corp. (VATE) increased its ATM offering limit to $50M, up from $31M, via a supplement filed with the SEC. The company sold DBMG for $413M in cash and shares, using $325M to redeem senior secured notes. Pro forma net loss for 9M 2026 was $23.5M, per the filing.
INNOVATE Corp. (VATE) filed an SEC Form 8-K — Other Events. Exhibit 99.1 INNOVATE CORP. UNAUDITED PRO FORMA FINANCIAL STATEMENTS INNOVATE Corp., a Delaware corporation ("INNOVATE" or the "Company"), has c ompleted the dispositions of (i) HC2 Broadcasting Holdings Inc. (“Broadcasting” or “HC2”) and its subsidiaries, and (ii) DBM Global Inc
Innovate Corp (VATE) reported Q3 2026 revenue of $495.5M (+42.8% YoY) and net income of $15.8M, reversing a prior-year loss. The DBM Global sale reduced debt from $583.3M to $238.3M. Infrastructure revenue rose 45%, while Life Sciences fell 61.3%. MediBeacon advanced commercialization, and R2 expanded production. The company sold a broadcasting stake but retains options. Pansend's portfolio holds potential milestone payments up to $900M. Cash position was $4.9M.
Over the past 7 days, AlphAI's AI scored 6 news stories mentioning VATE (INNOVATE Corp.). Coverage has skewed bullish: 3 bullish, 1 neutral, and 2 bearish.
Recent VATE coverage spans corporate actions, earnings and mergers & acquisitions.
The increased ATM capacity signals potential dilution and higher share supply.
The deconsolidation removes significant assets and revenue streams, likely pressuring the stock despite the one‑time gain.
Earnings beat and significant debt reduction likely improve credit profile and support upside.
Positive earnings and debt‑paydown steps
The amendment clarifies redemption timing, potentially reducing uncertainty for noteholders and may affect the stock's credit perception.
AlphAI scores every news story that mentions VATE with an AI model for sentiment and relevance, and aggregates insider trades from INNOVATE Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Innovate Corp. (VATE) increased its ATM offering limit to $50M, up from $31M, via a supplement filed with the SEC. The company sold DBMG for $413M in cash and shares, using $325M to redeem senior secured notes. Pro forma net loss for 9M 2026 was $23.5M, per the filing.
INNOVATE Corp. (VATE) filed an SEC Form 8-K — Other Events. Exhibit 99.1 INNOVATE CORP. UNAUDITED PRO FORMA FINANCIAL STATEMENTS INNOVATE Corp., a Delaware corporation ("INNOVATE" or the "Company"), has c ompleted the dispositions of (i) HC2 Broadcasting Holdings Inc. (“Broadcasting” or “HC2”) and its subsidiaries, and (ii) DBM Global Inc
Innovate Corp (VATE) reported Q3 2026 revenue of $495.5M (+42.8% YoY) and net income of $15.8M, reversing a prior-year loss. The DBM Global sale reduced debt from $583.3M to $238.3M. Infrastructure revenue rose 45%, while Life Sciences fell 61.3%. MediBeacon advanced commercialization, and R2 expanded production. The company sold a broadcasting stake but retains options. Pansend's portfolio holds potential milestone payments up to $900M. Cash position was $4.9M.
INNOVATE Corp. (VATE) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Third Quarter 2026 Results - Infrastructure: INNOVATE completes sale of DBM Global to IES Holdings - Life Sciences: MediBeacon continues to advance U.S. commercialization efforts, while progressing key reimbursement initiatives - Spe
INNOVATE amended its 9.5% Convertible Senior Secured Notes due 2027, mandating redemption at 100% of principal plus accrued interest after the DBMG stock lock-up expires. The lock-up ends on Dec. 4, 2026, or earlier if a resale registration statement is effective. The amendment clarifies no repurchase offer is required, providing clarity on the notes' retirement.
INNOVATE Corp. (VATE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement INNOVATE Corp., a Delaware corporation (the “Company”) has entered into a supplemental indenture (the “Supplemental Indenture”) to the indenture, dated August 4, 2025 (the “Indenture”), among the Company, certain subsidiary gua
Innovate Corp. (VATE) amended its convertible notes indenture, mandating redemption post-lockup. The company repaid $89.4M to terminate two credit facilities, reducing near-term debt. These actions follow the DBM Global transaction and aim to streamline its financial obligations.
Innovate Corp. (VATE) designated outstanding equity awards as Replacement Awards, preventing automatic vesting acceleration at the closing of a transaction. Vesting will now only accelerate upon involuntary termination within two years of closing, according to the company's SEC filing.
INNOVATE Corp. (VATE) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 INNOVATE Completes Sale of DBM Global to IES Holdings NEW YORK, October 5, 2026 ( Globe Newswire ) – INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has completed the previously announced sale of DBM Global, Inc. (“DBMG”) to IES Holdings, Inc. (Nasd
INNOVATE Corp. (VATE) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX NEW YORK, September 2, 2026 ( Globe Newswire ) – INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today the successful closing of the previously a
